Equity Overview
Price & Market Data
Price: $0.664
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $58,605,912
Daily Volume: 0
Performance Metrics
1 Week: 34.67%
1 Month: -34.91%
3 Months: -42.27%
6 Months: -64.87%
1 Year: -7.39%
YTD: -33.61%
Details
Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.